Prescription thyroid drug recalled due to temperature storage deviation
ARMOUR THYROID 120 mg tablets in batch W05543 are being recalled nationwide due to exposure to temperatures outside the labeled storage conditions. No illnesses or injuries have been reported.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA Class II recall due to storage temperature deviation, but no illnesses or injuries reported. The hazard is precautionary in nature—a potential loss of product stability from improper storage—rather than confirmed contamination or documented harm.
Plain-English summary
ARMOUR THYROID (thyroid, porcine), 2 grain (120 mg) tablets in batch W05543 are being recalled nationwide by Cardinal Healthcare due to current good manufacturing practice (CGMP) deviations. The product was exposed to temperatures outside of the manufacturer's labeled storage conditions during distribution.
The FDA has classified this as a Class II recall. Proper storage conditions for prescription medications are essential to maintain product integrity.
Patients taking ARMOUR THYROID from batch W05543 (NDC 0456-0461-01) should contact their pharmacist or healthcare provider to verify whether their medication is from the recalled batch. Patients should consult their healthcare provider before making any changes to their thyroid medication. No illnesses or injuries have been reported in connection with this recall.
The recalled product
- Product
- ARMOUR THYROID (THYROID, PORCINE)
- Brand
- ARMOUR THYROID
- Manufacturer
- CARDINAL HEALTHCARE
- Affected units
- 1
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Batch W05543
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 42 recalled by CARDINAL HEALTHCARE under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 42 products in this recall →Related recalls
Same manufacturer · CARDINAL HEALTHCARE
See all →- HighAlbuterol Sulfate Inhaler Recalled Due to Temperature Storage Deviation
FDA (Drugs) · 2024-01-03
- ModerateMeloxicam 15 mg tablets recalled for exposure to improper storage temperatures
FDA (Drugs) · 2024-01-03
- HighPredniSONE Tablets Recalled for Temperature Storage Deviation
FDA (Drugs) · 2024-01-03
- HighLow-dose aspirin recall due to improper storage temperature conditions
FDA (Drugs) · 2024-01-03
- HighBumetanide Tablets Recalled for Exposure to Improper Storage Temperatures
FDA (Drugs) · 2024-01-03
Same hazard · temperature excursion
See all →- ModerateCyclophosphamide injection vials recalled after a transportation temperature excursion
FDA (Drugs) · 2025-09-24
- ModerateXolair 75 mg syringes exposed to temperatures outside labeled storage requirements
FDA (Drugs) · 2025-08-13
- ModerateRecombinate antihemophilic factor vials exposed to temperatures outside labeled storage
FDA (Drugs) · 2025-08-13
- ModerateXolair auto-injectors exposed to temperatures outside labeled storage requirements
FDA (Drugs) · 2025-08-13
- ModerateProlia prefilled syringes recalled after potential temperature excursions during transit delays
FDA (Drugs) · 2025-07-30